Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for differential display

Journal of Rheumatology

Volumn 34, Issue 4, 2007, Pages 747-753

  Meyringer, Rotraud ^a,b   Neumann, Elena ^c   Judex, Martin ^a   Landthaler, Michael ^a   Kullmann, Frank ^a   Schölmerich, Jürgen ^a   Gay, Steffen ^d   Tarner, Ingo H ^c   Distler, Oliver ^d   Müller Ladner, Ulf ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Asklepios Klinikum Bad Abbach   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Differential display; Fibroblasts; Gene expression; Systemic sclerosis

Indexed keywords

COLLAGEN TYPE 12; COLLAGEN TYPE 12ALPHA 1 RECEPTOR; COMPLEMENTARY DNA; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; GENE PRODUCT; GREMLIN PROTEIN; ONCOPROTEIN C CBL; PHOSPHOLIPASE C GAMMA1; PLATELET DERIVED GROWTH FACTOR; PROTEIN LYSINE 6 OXIDASE; RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; ESTROGEN RESPONSIVE ELEMENT; FIBROBLAST; FIBROBLAST CULTURE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SKIN BIOPSY; SYSTEMIC SCLEROSIS;

CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN-LYSINE 6-OXIDASE; RNA, MESSENGER; SCLERODERMA, SYSTEMIC;

EID: 34247395864     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Perucho M, Welsh J, Peinado MA, Ionov Y, McClelland M. Fingerprinting of DNA and RNA by arbitrarily primed polymerase chain reaction: applications in cancer research. Methods Enzymol 1995;254:275-90.
2. Kullmann F, Judex M, Ballhorn W, et al. Kinesin-like protein CENP-E is upregulated in rheumatoid synovial fibroblasts. Arthritis Res 1999;1:71-80.
3. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
4. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology 1993;11:1026-30.
5. Morrison TB, Weis JJ, Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 1998;24:954-8.
6. Muller-Ladner U, Judex M, Jüsten HP, et al. Analysis of gene expression patterns in rheumatoid synovial fibroblasts using RAP-PCR for differential display. Med Klin (Munich) 1999;94:228-32.
7. Fleischmajer R, Perlish JS, Krieg T, Timpl R. Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 1981;76:400-3.
8. LeRoy EC. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 1974;54:880-9.
9. Kagan HM. Intra- and extracellular enzymes of collagen biosynthesis as biological and chemical targets in the control of fibrosis. Acta Trop 2000;77:147-52.
10. Kuivaniemi H, Peltonen L, Kivirikko KI. Type IX Ehlers-Danlos syndrome and Menkes syndrome: the decrease in lysyl oxidase activity is associated with a corresponding deficiency in the enzyme protein. Am J Hum Genet 1985;37:798-808.
11. Kagan HM. Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis. Pathol Res Pract 1994;190:910-9.
12. Murawaki Y, Kusakabe Y, Hirayama C. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin. Hepatology 1991;14:1167-73.
13. Streichenberger N, Peyrol S, Philit F, Loire R, Sommer P, Cordier JF. Constrictive bronchiolitis obliterans. Characterisation of fibrogenesis and lysyl oxidase expression patterns. Virchows Arch 2001;439:78-84.
14. Di Donato A, Ghiggeri GM, Di Duca M, et al. Lysyl oxidase expression and collagen cross-linking during chronic adriamycin nephropathy. Nephron 1997;76:192-200.
15. Decitre M, Gleyzal C, Raccurt M, et al. Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas. Lab Invest 1998;78:143-51.
16. Chanoki M, Ishii M, Kobayashi H, et al. Increased expression of lysyl oxidase in skin with scleroderma. Br J Dermatol 1995;133:710-5.
17. Kobayashi H, Ishii M, Chanoki M, et al. Immunohistochemical localization of lysyl oxidase in normal human skin. Br J Dermatol 1994;131:325-30.
18. Giampuzzi M, Botti G, Di Duca M, et al. Lysyl oxidase activates the transcription activity of human collagene III promoter. Possible involvement of Ku antigen. J Biol Chem 2000;275:36341-9.
19. Lazarus HM, Cruikshank WW, Narasimhan N, Kagan HM, Center DM. Induction of human monocyte motility by lysyl oxidase. Matrix Biol 1995;14:727-31.
20. Li W, Liu G, Chou IN, Kagan HM. Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of vascular smooth muscle cells. J Cell Biochem 2000;78:550-7.
21. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1998;1:673-83.
22. Merino R, Rodriguez-Leon J, Macias D, Ganan Y, Economides AN, Hurle JM. The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. Development 1999;126:5515-22.
23. Wang SN, Lapage J, Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 2001;12:2392-9.
24. Pereira RC, Economides AN, Canalis E. Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts. Endocrinology 2000;141:4558-63.
25. Vogt TF, Duboule D. Antagonists go out on a limb. Cell 1999;99:563-6.
26. Lappin DW, Hensey C, McMahon R, Godson C, Brady HR. Gremlins, glomeruli and diabetic nephropathy. Curr Opin Nephrol Hypertens 2000;9:469-72.
27. McMahon R, Murphy M, Clarkson M, et al. IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta 1. J Biol Chem 2000;275:9901-4.
28. Broome MA, Galisteo ML, Schlessinger J, Courtneidge SA. The proto-oncogene c-Cbl is a negative regulator of DNA synthesis initiated by both receptor and cytoplasmic tyrosine kinases. Oncogene 1999;18:2908-12.
29. Miyake S, Mullane-Robinson KP, Lill NL, Douillard P, Band H. Cbl-mediated negative regulation of platelet-derived growth factor receptor dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain. J Biol Chem 1999;274:16619-28.
30. Wang Z, Gluck S, Zhang L, Moran MF. Requirement for phospholipase C-gamma 1 enzymatic activity in growth factor-induced mitogenesis. Mol Cell Biol 1998;18:590-7.